drugset / Trial / NCT01659554

A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers

NCT01659554 ↗

Phase 2 Terminated 4 enrolled Columbia University
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to investigate the feasibility, tolerability and safety of surgical debulking and resection with heated intraoperative chemotherapy (HIPEC) followed by repeated intraperitoneal chemotherapy for treatment of recurrent ovarian, primary peritoneal, and fallopian tube carcinomas.

Timeline

Start
2012-03
Primary completion
2014-04
Completion
2014-04

Outcome

Outcome not reported

Stopped: “Principal Investigator left institution”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Other
Subject Doxorubicin Other / unclassified 25 mg Other